We are live on ! Find out more
SO

STRS Ohio Portfolio holdings

AUM $25.2B
1-Year Est. Return 30.31%
This Fund
S&P 500
This Quarter Est. Return
+23.23%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.9B
AUM Growth
+$3.89B
Cap. Flow
-$22.2M
Cap. Flow %
-0.1%
Top 10 Hldgs %
23.15%
Holding
2,333
New
311
Increased
958
Reduced
613
Closed
176

Top Buys

Rank Stock Value
1
GBDC icon
Golub Capital BDC
GBDC
+$74.9M
2
KEYS icon
Keysight
KEYS
+$52.1M
3
MRK icon
Merck
MRK
+$40.9M
4
ABBV icon
AbbVie
ABBV
+$38.6M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$37.7M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$104M
2
MTCH icon
Match Group
MTCH
+$48.9M
3
TDG icon
TransDigm Group
TDG
+$43.4M
4
SYK icon
Stryker
SYK
+$43.1M
5
JNJ icon
Johnson & Johnson
JNJ
+$42.5M

Sector Composition

Rank Sector Weight
1 Technology 23.57%
2 Financials 14.31%
3 Healthcare 13.92%
4 Consumer Discretionary 9.62%
5 Communication Services 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMD icon
1826
Viemed Healthcare
VMD
$451M
$84K ﹤0.01%
+8,800
New +$68.4K
BEN icon
1827
Franklin Resources
BEN
$16.9B
$83K ﹤0.01%
3,968
-17,521
-82% -$331K
FANG icon
1828
Diamondback Energy
FANG
$57.6B
$83K ﹤0.01%
1,987
-60,000
-97% -$2.45M
DMC
1829
Del Monte Corp
DMC
$1.35B
$83K ﹤0.01%
+3,400
New +$89.1K
RHI icon
1830
Robert Half
RHI
$3.61B
$83K ﹤0.01%
1,575
PETS icon
1831
PetMed Express
PETS
$42.5M
$81K ﹤0.01%
+2,300
New +$79.9K
ORC
1832
Orchid Island Capital
ORC
$1.31B
$80K ﹤0.01%
3,420
GEF.B icon
1833
Greif Class B
GEF.B
$3.65B
$79K ﹤0.01%
1,900
MHK icon
1834
Mohawk Industries
MHK
$6.9B
$79K ﹤0.01%
783
-11,922
-94% -$1.05M
BCRX icon
1835
BioCryst Pharmaceuticals
BCRX
$2.37B
$78K ﹤0.01%
+16,400
New +$65.5K
LYV icon
1836
Live Nation Entertainment
LYV
$41.2B
$78K ﹤0.01%
1,762
-125,000
-99% -$5.48M
AXTI icon
1837
AXT Inc
AXTI
$3.09B
$77K ﹤0.01%
+16,200
New +$76.3K
DVN icon
1838
Devon Energy
DVN
$51.9B
$77K ﹤0.01%
6,872
-24,529
-78% -$280K
ICFI icon
1839
ICF International
ICFI
$1.44B
$77K ﹤0.01%
1,200
-9,500
-89% -$623K
SMBC icon
1840
Southern Missouri Bancorp
SMBC
$855M
$77K ﹤0.01%
3,200
GSKY
1841
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$77K ﹤0.01%
+15,900
New +$68.1K
BCLI
1842
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$76K ﹤0.01%
+453
New +$48.8K
IBRX icon
1843
ImmunityBio
IBRX
$7.44B
$76K ﹤0.01%
+6,200
New +$35K
RVSB icon
1844
Riverview Bancorp
RVSB
$107M
$76K ﹤0.01%
13,500
FCBP
1845
DELISTED
First Choice Bancorp Common Stock
FCBP
$76K ﹤0.01%
4,700
HDS
1846
DELISTED
HD Supply Holdings, Inc.
HDS
$76K ﹤0.01%
2,200
JCAP
1847
DELISTED
Jernigan Capital, Inc.
JCAP
$76K ﹤0.01%
5,600
LNW
1848
DELISTED
Light & Wonder
LNW
$75K ﹤0.01%
+4,900
New +$64K
TEN
1849
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$75K ﹤0.01%
+10,000
New +$58.3K
ORIC icon
1850
Oric Pharmaceuticals
ORIC
$1.25B
$74K ﹤0.01%
+2,200
New +$70.2K

Similar funds

STRS Ohio's Q2 2020 Portfolio in Review

As of Q2 2020, STRS Ohio held 2,333 positions worth $22.9B, up 20% from $19B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

STRS Ohio's Q2 2020 filing shows 311 new, 958 increased, 613 reduced and 176 closed positions. Its largest new stake was RTX Corp: 598,060 shares worth $36.9M. The largest sale was Allergan plc, an estimated $104M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • STRS Ohio's largest Q2 2020 buy was RTX Corp: 598,060 shares worth $36.9M.
  • STRS Ohio added most to Golub Capital BDC in Q2 2020, an estimated $74.9M increase.
  • STRS Ohio's biggest Q2 2020 reduction was TransDigm Group, cutting an estimated $43.4M.
  • STRS Ohio fully exited Allergan plc in Q2 2020, selling an estimated $104M.
  • STRS Ohio's ten largest holdings make up 23% of its $22.9B portfolio in Q2 2020.
  • STRS Ohio opened 311 new positions and closed 176 in Q2 2020.
  • STRS Ohio's portfolio value rose 20% quarter-over-quarter to $22.9B.

Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.